Cargando…

Organizing knowledge to enable personalization of medicine in cancer

Interpretation of the clinical significance of genomic alterations remains the most severe bottleneck preventing the realization of personalized medicine in cancer. We propose a knowledge commons to facilitate collaborative contributions and open discussion of clinical decision-making based on genom...

Descripción completa

Detalles Bibliográficos
Autores principales: Good, Benjamin M, Ainscough, Benjamin J, McMichael, Josh F, Su, Andrew I, Griffith, Obi L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281950/
https://www.ncbi.nlm.nih.gov/pubmed/25222080
http://dx.doi.org/10.1186/s13059-014-0438-7
_version_ 1782351053116669952
author Good, Benjamin M
Ainscough, Benjamin J
McMichael, Josh F
Su, Andrew I
Griffith, Obi L
author_facet Good, Benjamin M
Ainscough, Benjamin J
McMichael, Josh F
Su, Andrew I
Griffith, Obi L
author_sort Good, Benjamin M
collection PubMed
description Interpretation of the clinical significance of genomic alterations remains the most severe bottleneck preventing the realization of personalized medicine in cancer. We propose a knowledge commons to facilitate collaborative contributions and open discussion of clinical decision-making based on genomic events in cancer.
format Online
Article
Text
id pubmed-4281950
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42819502015-01-03 Organizing knowledge to enable personalization of medicine in cancer Good, Benjamin M Ainscough, Benjamin J McMichael, Josh F Su, Andrew I Griffith, Obi L Genome Biol Opinion Interpretation of the clinical significance of genomic alterations remains the most severe bottleneck preventing the realization of personalized medicine in cancer. We propose a knowledge commons to facilitate collaborative contributions and open discussion of clinical decision-making based on genomic events in cancer. BioMed Central 2014-08-27 2014 /pmc/articles/PMC4281950/ /pubmed/25222080 http://dx.doi.org/10.1186/s13059-014-0438-7 Text en © Good et al.; licensee BioMed Central Ltd. 2014 The licensee has exclusive rights to distribute this article, in any medium, for 12 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Opinion
Good, Benjamin M
Ainscough, Benjamin J
McMichael, Josh F
Su, Andrew I
Griffith, Obi L
Organizing knowledge to enable personalization of medicine in cancer
title Organizing knowledge to enable personalization of medicine in cancer
title_full Organizing knowledge to enable personalization of medicine in cancer
title_fullStr Organizing knowledge to enable personalization of medicine in cancer
title_full_unstemmed Organizing knowledge to enable personalization of medicine in cancer
title_short Organizing knowledge to enable personalization of medicine in cancer
title_sort organizing knowledge to enable personalization of medicine in cancer
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281950/
https://www.ncbi.nlm.nih.gov/pubmed/25222080
http://dx.doi.org/10.1186/s13059-014-0438-7
work_keys_str_mv AT goodbenjaminm organizingknowledgetoenablepersonalizationofmedicineincancer
AT ainscoughbenjaminj organizingknowledgetoenablepersonalizationofmedicineincancer
AT mcmichaeljoshf organizingknowledgetoenablepersonalizationofmedicineincancer
AT suandrewi organizingknowledgetoenablepersonalizationofmedicineincancer
AT griffithobil organizingknowledgetoenablepersonalizationofmedicineincancer